Healthequity, Inc. (HQY): Filings, Insider Trades, Events

Quarter	Revenue	Net income	EPS
Q2 FY2027	$350.7M	$65.6M	0.78
Q1 FY2027	$354.6M	$69.4M	0.82
Q4 FY2026	$334.6M	$49.7M	0.58
Q3 FY2026	$322.2M	$51.7M	0.59

Form	Filed	Accepted (ET)
8-K	9 Oct 2026	9 Oct, 5:00 PM
8-K	30 Sep 2026	30 Sep, 9:02 AM
S-8	27 Aug 2026
10-Q	27 Aug 2026
8-K	27 Aug 2026
S-8	26 Jun 2026
8-K	26 Jun 2026
10-Q	28 May 2026

Financial statements

The income statement, balance sheet and cash flow by year and by quarter, line by line as the company reports them. Each column names the filing it comes from.

35 lines · 14 years · US$ millionsJSON

Fiscal period	FY2013	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Period ending	Jan 2013	Jan 2014	Jan 2015	Jan 2016	Jan 2017	Jan 2018	Jan 2019	Jan 2020	Jan 2021	Jan 2022	Jan 2023	Jan 2024	Jan 2025	Jan 2026
Source filing	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Filed	31 Mar 2015	31 Mar 2016	30 Mar 2017	28 Mar 2018	28 Mar 2019	31 Mar 2020	31 Mar 2021	31 Mar 2022	30 Mar 2023	22 Mar 2024	18 Mar 2025	17 Mar 2026	17 Mar 2026	17 Mar 2026
+Total revenue	46M	62M	88M	127M	178M	230M	287M	532M	734M	757M	862M	1,000M	1,200M	1,313M
−Total cost of revenue	22M	29M	40M	54M	72M	95M	106M	206M	318M	332M^r	370M^r	377M	423M	400M
Gross profit	24M	33M	48M	73M	106M	135M	181M	326M	415M	425M^r	492M^r	623M	777M	913M
% of total revenue	52.3%	52.9%	54.6%	57.3%	59.6%	58.8%	63.1%	61.3%	56.6%	56.1%	57.1%	62.3%	64.8%	69.5%
+Sales and marketing	7.8M	8.6M	11M	13M	18M	23M	30M	44M	50M	59M	69M	79M	91M	95M
+Technology and development	4.2M	7.1M	11M	17M	22M	27M	35M	78M	125M	157M	193M	219M	240M	263M
+General and administrative	3.4M	3.9M	8.3M	14M	20M	25M	33M	61M	85M	85M^r	98M^r	104M	132M	120M
+Amortization of acquired intangible assets	1.6M	1.6M	1.6M	2.2M	4.3M	4.9M	5.9M	35M	76M	83M	95M	93M	112M	108M
+Merger integration	–	–	–	–	–	0M	0M	32M	46M	65M	29M	10M	41M	5M
−Total operating expenses	17M	21M	31M	47M	65M	81M	104M	249M	381M	449M^r	483M^r	505M	615M	591M
Income from operations	7.1M	12M	17M	26M	41M	54M	78M	77M	34M	-24M	9.1M	118M	162M	323M
% of total revenue	15.4%	18.6%	19.2%	20.6%	23.1%	23.7%	27.0%	14.5%	4.6%	-3.2%	1.1%	11.8%	13.5%	24.6%
−Interest expense	0.3M	0M	0M	–	–	0.3M	0.3M	25M	35M	37M	48M	56M	61M	57M
+Other income, net	-0.6M	-6.1M	-1.1M	-0.6M	-1.1M	-2M^r	-1.6M^r	-9.1M	5M	-5.9M	1.3M	13M	14M	12M
Total other expense	–	–	–	–	–	-2.2M	-1.9M	-34M	-30M	-43M	-47M	-43M	-46M	-45M
Income before income taxes	6.5M	5.4M	16M	26M	40M	52M	76M	43M	4.1M	-67M	-38M	75M	116M	277M
% of total revenue	14.1%	8.7%	17.9%	20.2%	22.5%	22.7%	26.4%	8.1%	0.6%	-8.8%	-4.4%	7.5%	9.7%	21.1%
−Income tax provision	-4.7M	4.1M	5.6M	8.9M	14M	4.8M	1.9M	3.5M	-4.7M	-23M	-12M	19M	19M	62M
Net income	11M	1.2M	10M	17M	26M	47M	74M	40M	8.8M	-44M	-26M	56M	97M	215M
% of total revenue	24.2%	2.0%	11.6%	13.1%	14.8%	20.6%	25.7%	7.5%	1.2%	-5.9%	-3.0%	5.6%	8.1%	16.4%
Unrealized loss on available-for-sale marketable securities, net of tax	–	0M	0M	-0.1M	-0.1M	-0.1M	0M	0M	–	–	–	–	–	–
Comprehensive income	11M	1.2M	10M	17M	26M	47M	74M	40M	8.8M	-44M	-26M	56M	97M	–
Basic	0.81	-1.26	0.39	0.29	0.45	0.79	1.20	0.59	0.12	-0.53	-0.31	0.65	1.11	2.50
Diluted	0.25	-1.26	0.21	0.28	0.44	0.77	1.17	0.58	0.12	-0.53	-0.31	0.64	1.09	2.46
Basic	4.9M	5.7M	31M	57M	59M	60M	62M	67M	74M	83M	84M	86M	87M	86M
Diluted	38M	5.7M	52M	59M	60M	62M	63M	69M	76M	83M	84M	87M	89M	88M

Hover a figure for its source.^r restated in a later filing– not reported in that period

Lines in the order and wording of the 10-K filed 17 Mar 2026. 338 of 338 subtotals add up to the company's own totals, and the balance sheet balances in 61 of 61 periods. Newest filing read: 27 Aug 2026.

Free for personal research, with credit (Data by Shikshan Nivesh) and a link. API access, bulk files and commercial use need a licence: the data licence.

Charts

Any figure or ratio in the record, by year, by quarter or on a trailing twelve months, as a value or as growth, against a peer if you like. Hover for the figures.

Revenue · quarterly · US$

Latest Jul 2026: $350.73M

HQY · Healthequity, Inc.From2014to2026

Revenue = rev

$350.7M · Jul 2026

7.6% · Jul 2026

−1.1% · Jul 2026

71.2% · Jul 2026

GrossOperatingNet

$65.6M · Jul 2026

$487.7M · Jul 2026

$0.78 · Jul 2026

87.5M · Jan 2026

$256M · Jul 2026

CashDebt

8.9% · Jan 2026

$457.1M · Jan 2026

Operating cash flowCapital spending

Revenue by segment, by product

CustodialServiceInterchangeEach fiscal year as its annual report gives it.

Price at its own past P/E range

HQY $104.01 · 37.5× P/E · 23 Oct 2026

Month-end priceAt its median P/E, 106.5×Between its 10th and 90th percentile, 37.5× to 1065.0×

Method. Each month-end, the trailing-twelve-month diluted EPS known that month (from filings filed by then) at the 10th, 50th and 90th percentile of this stock's own month-end P/E from 2015-09 to 2026-10. Months with the figure at or below zero are left out. A summary of the multiples the stock has traded at, not a value.

Ratios

Every ratio, worked out the same way for every company, by year or on a trailing twelve months. Hover a ratio for its formula.

145 ratios · 14 in profitabilityJSON

Fiscal year ending	Jan 2013	Jan 2014	Jan 2015	Jan 2016	Jan 2017	Jan 2018	Jan 2019	Jan 2020	Jan 2021	Jan 2022	Jan 2023	Jan 2024	Jan 2025	Jan 2026
Return on common equity	–	–	n/m	9.6%	11.3%	15.6%	18.0%	5.3%	0.7%	−2.7%	−1.4%	2.8%	4.7%	10.2%
Return on assets	–	–	9.5%	8.8%	10.6%	14.6%	16.8%	2.6%	0.3%	−1.5%	−0.8%	1.8%	2.9%	6.3%
Return on capital	–	–	16.6%	9.8%	11.6%	16.2%	18.4%	5.2%	1.2%	−0.6%	0.2%	3.0%	4.4%	8.0%
Return on invested capital	–	–	336.5%	22.2%	22.4%	36.7%	57.7%	6.5%	1.3%	−0.7%	0.2%	3.4%	5.0%	8.9%
Gross margin	52.3%	52.9%	54.6%	57.3%	59.6%	58.8%	63.1%	61.3%	56.6%	56.1%	57.1%	62.3%	64.8%	69.5%
EBITDA margin	22.7%	25.5%	25.9%	27.4%	30.5%	30.7%	33.4%	24.9%	20.4%	14.9%	19.8%	27.1%	27.1%	36.3%
Operating margin	15.4%	18.6%	19.2%	20.6%	23.1%	23.7%	27.0%	14.5%	4.6%	−3.2%	1.1%	11.8%	13.5%	24.6%
Incremental operating margin	–	27.8%	20.7%	23.8%	29.2%	25.8%	40.3%	−0.3%	−21.3%	−253.4%	31.7%	78.8%	22.3%	140.9%
Pretax margin	14.1%	8.7%	17.9%	20.2%	22.5%	22.7%	26.4%	8.1%	0.6%	−8.8%	−4.4%	7.5%	9.7%	21.1%
Profit margin	24.2%	2.0%	11.6%	13.1%	14.8%	20.6%	25.7%	7.5%	1.2%	−5.9%	−3.0%	5.6%	8.1%	16.4%
Net income to common margin	8.7%	−11.5%	13.7%	13.1%	14.8%	20.6%	25.7%	7.5%	1.2%	−5.9%	−3.0%	5.6%	8.1%	16.4%
Effective tax rate	−71.8%	n/m	35.5%	35.0%	34.3%	9.2%	2.5%	8.1%	−113.4%	n/m	n/m	25.8%	16.7%	22.4%
Dividend payout ratio	0.0%	n/m	417.5%	0.0%	0.0%	–	–	–	–	–	–	–	–	–
Sustainable growth rate	–	–	n/m	9.6%	11.3%	–	–	–	–	–	–	–	–	–

Hover a ratio for its formula as computed; n/m marks a ratio over a negative base, such as debt over negative equity, with the reason on hover; avg() is the mean of the line now and a year earlier. The bar mark charts it. Worked out the same way for every company, from the standardized statements. Newest filing read: 27 Aug 2026.

What the company said with its results

The key points, guidance and management's own words from each of the last four results releases.

Key points

Revenue rose 8% year over year
Revenue was $350.7 million against $325.8 million a year earlier. Service revenue was $124.4 million, custodial revenue $175.9 million and interchange revenue $50.4 million.
Net income and per-share earnings rose
Net income was $65.6 million, or $0.78 per diluted share, against $59.9 million, or $0.68 per diluted share, a year earlier. Net income margin was 19% against 18%.
Non-GAAP per-share earnings up 15%
Non-GAAP net income was $103.8 million, or $1.24 per diluted share, against $1.08 a year earlier.
Adjusted EBITDA margin rose to 48%
Adjusted EBITDA was $167.0 million, up 11%, and 48% of revenue against 46% a year earlier.
Technology and G&A spending rose
Technology and development expense rose to $73.9 million from $64.8 million. General and administrative expense rose to $34.9 million from $30.0 million.
Service costs were lower
Service costs were $73.2 million against $75.2 million a year earlier. Total cost of revenue was $92.8 million against $93.2 million.
Stock compensation expense increased
Stock-based compensation expense was $22.2 million against $19.1 million a year earlier, and income tax provision was $22.2 million against $18.2 million.
HSA count reached 10.7 million
HSAs were 10.7 million, up 8% year over year. New HSAs from sales were 202 thousand, up 24%. HSAs with investments were 0.9 million, up 20%.
HSA Assets grew 14% to $37.9 billion
Total HSA Assets were $37.9 billion at July 31, 2026, up 14% from a year earlier.
Investments grew faster than cash
HSA investments were $20.6 billion, up 28% year over year. HSA cash was $17.4 billion, up 2%.
Total Accounts 17.8 million
Total Accounts were 17.8 million, up 4%, including 7.0 million complementary CDBs, which were down 2% year over year.
Client-held funds fell from prior quarter
Client-held funds were $0.9 billion at July 31, 2026, against $1.0 billion at April 30, 2026, and up 14% from a year earlier.
Most HSA cash reprices after fiscal 2027
Of the HSA cash schedule, $2.3 billion reprices in the remainder of fiscal 2027 at a 1.5% average annualized yield.
Repricing schedule totals $16.7 billion
Total HSA cash expected to reprice is $16.7 billion at a 3.9% average annualized yield. Thereafter, $7.8 billion reprices at 4.4%. $0.7 billion in floating-rate contracts is excluded.

Guidance

Revenue$1.411 billion to $1.421 billionfiscal year ending January 31, 2027 · raised from $1.410 billion to $1.420 billion
Net income$242 million to $248 millionfiscal year ending January 31, 2027 · kept from $242 million to $248 million
GAAP net income per diluted share$2.88 to $2.96fiscal year ending January 31, 2027 · raised from $2.88 to $2.95
Non-GAAP net income$392 million to $398 millionfiscal year ending January 31, 2027 · kept from $392 million to $398 million
Non-GAAP net income per diluted share$4.66 to $4.73fiscal year ending January 31, 2027 · kept from $4.66 to $4.73
Adjusted EBITDA$628 million to $636 millionfiscal year ending January 31, 2027 · raised from $625 million to $633 million
Diluted weighted-average shares84 millionfiscal year ending January 31, 2027 · kept from 84 million
Depreciation and amortization (reconciling item)54fiscal year ending January 31, 2027 · raised from 50
Interest income (reconciling item)(7)fiscal year ending January 31, 2027 · raised from (6)
Interest expense (reconciling item)50fiscal year ending January 31, 2027 · kept from 50
Income tax provision (reconciling item)81 - 83fiscal year ending January 31, 2027 · kept from 81 - 83
Stock-based compensation expense (reconciling item)87fiscal year ending January 31, 2027 · kept from 87
Merger integration expenses (reconciling item)5fiscal year ending January 31, 2027 · lowered from 6

In their words

“These results reflect strong execution across the business and the durability of our model as growth comes from more places, member relationships deepen and technology-enabled efficiency improves how we serve members and clients.” Scott Cutler, President and CEO of HealthEquity

“This momentum gives us confidence to raise fiscal 2027 guidance and enter the second half focused on scaling efficiently and creating long-term value.” Scott Cutler, President and CEO of HealthEquity

Coming up

Conference call on August 27, 2026. Management said it would host a conference call at 8:30 a.m. Eastern on August 27, 2026 to discuss second-quarter results.

Revenue by segment

As the company reports it in the segment note of each annual report: by business, by product and by region, latest year.

By product, FY2026

Custodial$636.8M 48.5%
Service$485.0M 36.9%
Interchange$191.6M 14.6%

10 years held, FY2017 to FY2026

Company events

Every 8-K, sorted by the event it reports, with the moment the SEC accepted it in New York time.


9 Oct 2026	9 Oct, 5:00 PM ET	8-K	Leadership change	5.02
30 Sep 2026	30 Sep, 9:02 AM ET	8-K	Leadership changeInvestor update	5.02, 7.01
27 Aug 2026		8-K	Results	2.02, 9.01
26 Jun 2026		8-K	Shareholder vote	5.07, 9.01
28 May 2026		8-K	Results	2.02, 9.01
8 May 2026		8-K	Leadership change	5.02, 9.01
6 Apr 2026		8-K	Leadership change	5.02, 9.01
30 Mar 2026		8-K	Leadership changeInvestor update	5.02, 7.01, 9.01
17 Mar 2026		8-K	Results	2.02, 9.01
17 Feb 2026		8-K	Results	2.02, 9.01
12 Jan 2026		8-K	Investor update	7.01, 9.01
3 Dec 2025		8-K	Results	2.02, 9.01
2 Sep 2025		8-K	Results	2.02, 9.01
27 Jun 2025		8-K	Shareholder voteInvestor update	5.07, 7.01, 9.01
3 Jun 2025		8-K	Results	2.02, 9.01
28 Apr 2025		8-K	Leadership change	5.02, 9.01
18 Mar 2025		8-K	Results	2.02, 9.01
18 Feb 2025		8-K	Results	2.02, 9.01
13 Jan 2025		8-K	Investor update	7.01, 9.01
9 Dec 2024		8-K	Results	2.02, 9.01
29 Nov 2024		8-K	Material agreement	1.01, 9.01
12 Nov 2024		8-K	Leadership changeInvestor update	5.02, 7.01, 9.01
3 Sep 2024		8-K	Results	2.02, 9.01
27 Aug 2024		8-K	Material agreementAgreement endedNew debt	1.01, 1.02, 2.03, 9.01
2 Jul 2024		8-K	Other events	8.01, 9.01
27 Jun 2024		8-K	Leadership changeShareholder vote	5.02, 5.07, 9.01
3 Jun 2024		8-K	Results	2.02, 9.01
28 May 2024		8-K	Investor update	7.01, 9.01
14 May 2024		8-K	Deal completedInvestor update	2.01, 7.01, 9.01
25 Apr 2024		8-K	Leadership change	5.02, 9.01
15 Apr 2024		8-K	Investor update	7.01, 9.01
19 Mar 2024		8-K	Results	2.02, 9.01
13 Mar 2024		8-K	Investor update	7.01, 9.01
21 Feb 2024		8-K	Results	2.02, 9.01
8 Jan 2024		8-K	Investor update	7.01, 9.01
5 Dec 2023		8-K	Results	2.02, 9.01
19 Sep 2023		8-K	Material agreementInvestor update	1.01, 7.01, 9.01
5 Sep 2023		8-K	Results	2.02, 9.01
28 Jul 2023		8-K	Leadership change	5.02, 9.01
3 Jul 2023		8-K	Leadership change	5.02, 9.01
22 Jun 2023		8-K	Shareholder vote	5.07, 9.01
14 Jun 2023		8-K	Leadership change	5.02, 9.01
5 Jun 2023		8-K	Results	2.02, 9.01
2 Jun 2023		8-K	Material agreementNew debt	1.01, 2.03, 9.01
13 Apr 2023		8-K	Leadership change	5.02, 9.01
21 Mar 2023		8-K	Results	2.02, 9.01
13 Mar 2023		8-K	Investor update	7.01, 9.01
14 Feb 2023		8-K	Results	2.02, 9.01
10 Feb 2023		8-K	Bylaws or fiscal year change	5.03, 9.01
9 Jan 2023		8-K	Investor update	7.01, 9.01

1–50 of 150

8-K events each year

0102030

'14'18'22'26

Every filing

The company's filings with the SEC, newest first: 312 held. Insider, fund and large-holder filings have their own tables below.


9 Oct 2026	8-K	5 Oct 2026	9 Oct, 5:00 PM ET
30 Sep 2026	8-K	24 Sep 2026	30 Sep, 9:02 AM ET
27 Aug 2026	S-8	–
27 Aug 2026	10-Q	31 Jul 2026
27 Aug 2026	8-K	27 Aug 2026
26 Jun 2026	S-8	–
26 Jun 2026	8-K	25 Jun 2026
28 May 2026	10-Q	30 Apr 2026
28 May 2026	8-K	28 May 2026
13 May 2026	ARS	31 Jan 2026
13 May 2026	DEFA14A	–
13 May 2026	DEF 14A	31 Jan 2026
8 May 2026	8-K	5 May 2026
6 Apr 2026	8-K	6 Apr 2026
30 Mar 2026	8-K	26 Mar 2026
17 Mar 2026	10-K	31 Jan 2026
17 Mar 2026	8-K	17 Mar 2026
17 Feb 2026	8-K	17 Feb 2026
5 Feb 2026	UPLOAD	–
29 Jan 2026	CORRESP	–
27 Jan 2026	UPLOAD	–
12 Jan 2026	8-K	12 Jan 2026
3 Dec 2025	10-Q	31 Oct 2025
3 Dec 2025	8-K	3 Dec 2025
2 Sep 2025	10-Q	31 Jul 2025
2 Sep 2025	8-K	2 Sep 2025
27 Jun 2025	8-K	26 Jun 2025
3 Jun 2025	10-Q	30 Apr 2025
3 Jun 2025	8-K	3 Jun 2025
13 May 2025	ARS	31 Jan 2025
13 May 2025	DEFA14A	–
13 May 2025	DEF 14A	31 Jan 2025
28 Apr 2025	8-K	22 Apr 2025
18 Mar 2025	10-K	31 Jan 2025
18 Mar 2025	8-K	18 Mar 2025
18 Feb 2025	8-K	18 Feb 2025
13 Jan 2025	8-K	13 Jan 2025
9 Dec 2024	10-Q	31 Oct 2024
9 Dec 2024	8-K	9 Dec 2024
29 Nov 2024	8-K	27 Nov 2024
12 Nov 2024	8-K	11 Nov 2024
6 Sep 2024	S-3ASR	–
3 Sep 2024	10-Q	31 Jul 2024
3 Sep 2024	8-K	3 Sep 2024
27 Aug 2024	8-K	23 Aug 2024
5 Jul 2024	S-8 POS	–
5 Jul 2024	S-8 POS	–
5 Jul 2024	S-8 POS	–
5 Jul 2024	S-8 POS	–
5 Jul 2024	S-8 POS	–

1–50 of 150

Insider trades

Form 4 trades by officers, directors and 10% owners, last 12 months, with the shares they held after.


15 Oct 2026	Rajasekar SunilEVP Chief Prod & Strat Officer	Purchase	108	$90.33	$9.8K	53,405	19 Oct 2026
24 Aug 2026	Rajasekar SunilEVP Chief Prod & Strat Officer	Sale outside a trading plan	108	$105.60	$11.4K	53,297	19 Oct 2026
8 Jul 2026	Rajasekar SunilEVP Chief Prod & Strat Officer	Purchase	23	$95.06	$2.2K	53,405	19 Oct 2026
22 Apr 2026	Rajasekar SunilEVP Chief Prod & Strat Officer	Sale outside a trading plan	23	$82.81	$1.9K	53,382	19 Oct 2026
25 Aug 2026	Dillon Adrian TDirector	Sale under a trading plan	6,300	$104.47	$658.2K	63,727	27 Aug 2026
25 Aug 2026	Dillon Adrian TDirector	Sale under a trading plan	1,332	$105.26	$140.2K	62,395	27 Aug 2026
10 Jul 2026	Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER	Sale under a trading plan	2,354	$95.00	$223.6K	52,244	14 Jul 2026
2 Jul 2026	Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER	Sale under a trading plan	2,470	$95.00	$234.7K	56,643	7 Jul 2026
29 May 2026	Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER	Sale under a trading plan	3,142	$95.00	$298.5K	59,113	2 Jun 2026
28 May 2026	Wellborn Gayle FurgursonDirector	Sale under a trading plan	2,439	$90.00	$219.5K	19,733	1 Jun 2026
28 May 2026	Ladd DelanoEVP, General Counsel	Sale under a trading plan	7,500	$90.00	$675.0K	91,141	1 Jun 2026
19 Dec 2025	Ladd DelanoEVP, General Counsel	Sale under a trading plan	1,500	$94.72	$142.1K	73,979	23 Dec 2025
18 Dec 2025	Rosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER	Sale outside a trading plan	10,959	$95.45	$1.0M	45,742	19 Dec 2025
12 Dec 2025	Wellborn Gayle FurgursonDirector	Sale outside a trading plan	4,339	$98.03	$425.3K	19,733	16 Dec 2025
20 Nov 2025	Ladd DelanoEVP, General Counsel	Sale under a trading plan	1,500	$104.56	$156.8K	75,479	24 Nov 2025
20 Oct 2025	Ladd DelanoEVP, General Counsel	Sale under a trading plan	1,500	$92.07	$138.1K	76,979	22 Oct 2025

Planned insider sales

Form 144 notices, filed when the sell order goes to the broker.


8 Oct 2026	Michael GathrightOfficer	662	$60.3K	6 Oct 2026
8 Oct 2026	Delano LaddOfficer	1,080	$98.4K	6 Oct 2026
8 Oct 2026	Stephen NeelemanOfficer, Director	1,095	$99.8K	6 Oct 2026
8 Oct 2026	Scott CutlerOfficer, Director	1,230	$112.1K	6 Oct 2026
8 Oct 2026	Michael Henry FioreFormer EVP, CCO	2,032	$185.2K	6 Oct 2026
8 Oct 2026	James M. LucaniaOfficer	2,822	$257.2K	6 Oct 2026
25 Aug 2026	ADRIAN DILLONDirector	7,632	$804.4K	25 Aug 2026
13 Jul 2026	Michael GathrightOfficer	2,270	$211.3K	9 Jul 2026
10 Jul 2026	Delano LaddOfficer	1,087	$103.4K	8 Jul 2026
10 Jul 2026	Stephen NeelemanOfficer, Director	1,103	$104.9K	8 Jul 2026
10 Jul 2026	Scott CutlerOfficer, Director	1,238	$117.7K	8 Jul 2026
10 Jul 2026	Michael Henry FioreOfficer	2,045	$194.4K	8 Jul 2026
10 Jul 2026	MICHAEL FIOREOfficer	2,354	$223.2K	10 Jul 2026
10 Jul 2026	James M. LucaniaOfficer	2,839	$269.9K	8 Jul 2026
2 Jul 2026	MICHAEL FIOREOfficer	2,470	$228.0K	2 Jul 2026
29 May 2026	MICHAEL FIOREOfficer	3,142	$284.4K	29 May 2026
28 May 2026	GAYLE WELLBORNDirector	2,439	$211.1K	28 May 2026
28 May 2026	DELANO LADDOfficer	7,500	$649.2K	28 May 2026
8 Apr 2026	Delano LaddOfficer	2,481	$208.0K	6 Apr 2026
8 Apr 2026	Stephen NeelemanOfficer, Director	2,559	$214.5K	6 Apr 2026
8 Apr 2026	Michael Henry FioreOfficer	3,378	$283.2K	6 Apr 2026
8 Apr 2026	James M. LucaniaOfficer	4,393	$368.3K	6 Apr 2026
8 Apr 2026	Elimelech RosnerOfficer	4,768	$399.7K	6 Apr 2026
8 Apr 2026	Scott CutlerOfficer, Director	4,931	$413.4K	6 Apr 2026
2 Apr 2026	Delano LaddOfficer	7,726	$637.6K	31 Mar 2026
2 Apr 2026	Stephen NeelemanOfficer, Director	9,292	$766.8K	31 Mar 2026
2 Apr 2026	Elimelech RosnerOfficer	18,010	$1.5M	31 Mar 2026
14 Jan 2026	Scott CutlerOfficer, Director	12,496	$1.1M	12 Jan 2026
13 Jan 2026	Delano LaddOfficer	739	$70.4K	9 Jan 2026
13 Jan 2026	Stephen NeelemanOfficer, Director	791	$75.3K	9 Jan 2026
13 Jan 2026	Michael Henry FioreOfficer	1,744	$166.1K	9 Jan 2026
13 Jan 2026	Elimelech RosnerOfficer	2,074	$197.5K	9 Jan 2026
13 Jan 2026	James M. LucaniaOfficer	2,470	$235.2K	9 Jan 2026
19 Dec 2025	DELANO LADDOfficer	4,500	$429.8K	19 Dec 2025
18 Dec 2025	ELIMELECH ROSNEROfficer	10,959	$1.0M	18 Dec 2025
12 Dec 2025	GAYLE F WELLBORNDirector	4,339	$425.3K	12 Dec 2025

Large holders

Schedule 13D and 13G filings by holders of more than 5% of the voting shares.


9 Oct 2026	Wasatch Advisors LP	13G amended	8.5%	7.0M
31 Jul 2026	Vanguard Portfolio Management	13G amended	4.94%	4.1M
15 Jul 2026	Wasatch Advisors LP	13G amended	9.5%	8.0M
30 Apr 2026	Vanguard Capital Management	13G	5.3%	4.5M
29 Apr 2026	Vanguard Portfolio Management	13G	5.01%	4.2M
27 Mar 2026	The Vanguard Group	13G amended	0%	0
5 Nov 2025	FMR LLC	13G amended	4.1%	3.5M

Trades by members of the House

From each member's periodic transaction report: the amount is the band the report gives.


10 Jul 2026	Gilbert CisnerosCA31	Purchase	$1,001 - $15,000	Self	4 Sep 2026
30 Jun 2026	Gilbert CisnerosCA31	Purchase	$1,001 - $15,000	Self	2 Jul 2026
29 May 2026	Gilbert CisnerosCA31	Purchase	$1,001 - $15,000	Self	8 Jun 2026
11 Jun 2025	Lisa McClainMI09	Purchase	$1,001 - $15,000	SP	13 Aug 2025
17 Jun 2025	Lisa McClainMI09	Sale	$1,001 - $15,000	SP	13 Aug 2025
16 Jun 2025	Gilbert CisnerosCA31	Sale (partial)	$1,001 - $15,000	Self	10 Jul 2025
13 Jan 2025	Rob BresnahanPA08	Sale	$1,001 - $15,000	JT	13 Feb 2025
7 Nov 2024	Josh GottheimerNJ05	Sale (partial)	$1,001 - $15,000	JT	5 Dec 2024
21 Jun 2024	Josh GottheimerNJ05	Sale (partial)	$1,001 - $15,000	JT	9 Jul 2024
19 Jan 2024	Blake MooreUT01	Sale	$1,001 - $15,000	Self	24 Jan 2024
10 Apr 2023	Daniel GoldmanNY10	Sale	$15,001 - $50,000	Self	19 May 2023
10 Jan 2022	Josh GottheimerNJ05	Purchase	$1,001 - $15,000	JT	18 Feb 2022
9 Dec 2021	Josh GottheimerNJ05	Sale (partial)	$1,001 - $15,000	JT	10 Jan 2022
26 Mar 2021	Blake MooreUT01	Purchase	$1,001 - $15,000	Self	17 Jul 2021
30 Apr 2021	Blake MooreUT01	Purchase	$1,001 - $15,000	Self	17 Jul 2021
11 May 2021	Blake MooreUT01	Purchase	$1,001 - $15,000	Self	17 Jul 2021
12 May 2021	Blake MooreUT01	Purchase	$1,001 - $15,000	Self	17 Jul 2021
17 Jul 2020	Gilbert CisnerosCA39	Purchase	$1,001 - $15,000	Self	19 Aug 2020
9 Jul 2020	Josh GottheimerNJ05	Purchase	$1,001 - $15,000	JT	10 Aug 2020
7 Apr 2020	Gilbert CisnerosCA39	Purchase	$1,001 - $15,000	Self	13 May 2020
3 Apr 2020	Josh GottheimerNJ05	Purchase	$1,001 - $15,000	JT	13 May 2020
31 Mar 2020	Gilbert CisnerosCA39	Purchase	$1,001 - $15,000	Self	16 Apr 2020
26 Mar 2020	Josh GottheimerNJ05	Purchase	$1,001 - $15,000	JT	11 Apr 2020

Short interest

Shares sold short and not yet bought back, on every FINRA settlement date.

Shares short, each settlement


30 Sep 2026	6.0M	+24.82%	6.09
15 Sep 2026	4.8M	+6.31%	6.38
31 Aug 2026	4.5M	+9.68%	4.32
14 Aug 2026	4.1M	-1.19%	6.5
31 Jul 2026	4.2M	-17.26%	5.93
15 Jul 2026	5.0M	-4.36%	6.01
30 Jun 2026	5.3M	+14.31%	4.46
15 Jun 2026	4.6M	+11.57%	5.16
29 May 2026	4.1M	-8.28%	3.47
15 May 2026	4.5M	-10.99%	5.64

1–10 of 211

Funds that hold it

Every fund's holding from its latest Form 13F, largest first, with what it added or trimmed in the quarter.

Funds holding

558

quarter to 30 Jun 2026

Added or new

271

since 31 Mar 2026

Trimmed

156

in the quarter

Largest holder

BlackRock, Inc.

$1.0B

The 60 largest of 558 funds, by value


BlackRock, Inc.	$1.0B	11.3M	+745.5K	Added	0.01%	Filing ↗
Wasatch Advisors LP	$719.0M	8.0M	+757.8K	Added	4.71%	Filing ↗
Morgan Stanley	$410.7M	4.5M	+2.1M	Added	0.02%	Filing ↗
Vanguard Portfolio Management LLC	$366.5M	4.1M	-106.0K	Trimmed	0.02%	Filing ↗
Vanguard Capital Management LLC	$328.8M	3.6M	-183.0K	Trimmed	0.01%	Filing ↗
State Street Corp.	$292.7M	3.2M	+141.1K	Added	0.01%	Filing ↗
Geode Capital Management, LLC	$214.5M	2.4M	+114.8K	Added	0.01%	Filing ↗
AQR Capital Management LLC	$176.1M	2.0M	-93.0K	Trimmed	0.06%	Filing ↗
Dimensional Fund Advisors LP	$168.8M	1.9M	+242.0K	Added	0.03%	Filing ↗
William Blair Investment Management, LLC	$160.2M	1.8M	+113.6K	Added	0.48%	Filing ↗
FMR LLC	$138.9M	1.5M	+403.5K	Added	0.01%	Filing ↗
Brown Advisory Inc.	$124.0M	1.4M	-40.2K	Trimmed	0.19%	Filing ↗
Clearbridge Investments, LLC	$117.1M	1.3M	-13.2K	Trimmed	0.10%	Filing ↗
Charles Schwab Investment Management Inc.	$107.4M	1.2M	+13.6K	Added	0.01%	Filing ↗
Greenhouse Funds LLLP	$106.9M	1.2M	-74.8K	Trimmed	5.63%	Filing ↗
Geneva Capital Management LLC	$103.8M	1.1M	-24.4K	Trimmed	2.38%	Filing ↗
Bank of America Corp.	$103.6M	1.1M	+284.7K	Added	0.01%	Filing ↗
JPMorgan Chase & Co.	$102.1M	1.2M	-24.6K	Trimmed	0.01%	Filing ↗
Davenport & Co LLC	$98.2M	1.1M	+71.8K	Added	0.50%	Filing ↗
Northern Trust Corp.	$96.8M	1.1M	+35.9K	Added	0.01%	Filing ↗
Goldman Sachs Group Inc.	$91.0M	1.0M	+206.6K	Added	0.01%	Filing ↗
Price T Rowe Associates Inc.	$89.8M	994.6K	+191.1K	Added	0.01%	Filing ↗
Arrowstreet Capital, Limited Partnership	$87.2M	965.8K	+963.0K	Added	0.04%	Filing ↗
Atalan Capital Partners, LP	$82.7M	915.3K	+31.6K	Added	5.07%	Filing ↗
Loomis Sayles & Co. L P	$82.1M	908.6K	-23.4K	Trimmed	0.10%	Filing ↗
Jupiter Topco LLC	$78.8M	873.0K	–	first	0.03%	Filing ↗
Swedbank AB	$76.9M	851.4K	+145.1K	Added	0.07%	Filing ↗
Park West Asset Management LLC	$70.1M	776.7K	+153.5K	Added	4.79%	Filing ↗
American Century Companies Inc.	$68.6M	760.0K	+17.1K	Added	0.03%	Filing ↗
Bamco Inc.	$67.8M	750.4K	+369	Held	0.10%	Filing ↗
Nuveen, LLC	$66.2M	732.8K	+52.3K	Added	0.02%	Filing ↗
Stephens Investment Management Group LLC	$65.9M	729.1K	+44.5K	Added	0.71%	Filing ↗
Westfield Capital Management Co. LP	$63.5M	703.3K	-9.5K	Trimmed	0.21%	Filing ↗
Sei Investments Co.	$61.7M	683.3K	+80.6K	Added	0.05%	Filing ↗
Citadel Advisors LLC	$61.7M	683.0K	+414.1K	Added	0.04%	Filing ↗
Nomura Asset Management International Inc.	$61.3M	678.5K	+86.5K	Added	0.09%	Filing ↗
Bank of New York Mellon Corp	$60.2M	666.3K	+67.0K	Added	0.01%	Filing ↗
GW&K Investment Management, LLC	$57.1M	632.4K	+168.1K	Added	0.45%	Filing ↗
Cadian Capital Management, LP	$56.6M	626.7K	-206.0K	Trimmed	4.28%	Filing ↗
Vanguard Fiduciary Trust Co.	$54.4M	601.8K	+7.4K	Added	0.01%	Filing ↗
Norges Bank	$48.2M	533.9K	–	Held	0.01%	Filing ↗
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.	$41.3M	456.9K	+456.9K	New	2.26%	Filing ↗
UBS Group AG	$39.3M	435.5K	-351.2K	Trimmed	0.01%	Filing ↗
Raymond James Financial Inc.	$39.0M	432.0K	+51.5K	Added	0.01%	Filing ↗
Kayne Anderson Rudnick Investment Management LLC	$36.2M	400.6K	-84.8K	Trimmed	0.11%	Filing ↗
Wellington Management Group LLP	$35.0M	387.9K	-109.6K	Trimmed	0.01%	Filing ↗
Artisan Partners Limited Partnership	$34.7M	384.1K	+113.2K	Added	0.06%	Filing ↗
Franklin Resources Inc.	$32.6M	360.7K	+19.3K	Added	0.01%	Filing ↗
12th Street Asset Management Company, LLC	$31.2M	345.4K	+94.0K	Added	4.45%	Filing ↗
Aristotle Capital Boston, LLC	$30.1M	332.9K	-64.3K	Trimmed	2.02%	Filing ↗

1–50 of 60

Executive pay and performance

What the chief executive and the other named officers were paid, as reported and as actually paid, next to the shareholder return and net income, from each proxy's pay-versus-performance table.

Pay versus performance

6 fiscal years · from each proxy (DEF 14A)

Fiscal year	CEO pay, as reported	CEO pay, actually paid	Other officers, as reported (average)	Other officers, actually paid (average)	Shareholder return, $100	Peer return, $100	Net income	Adjusted EBITDA	Proxy
FY ending 31 Jan 2026	$13.6M	$10.4M	$4.4M	$0.6M	$103	$81	$215.2M	$566.0M	DEF 14A 13 May 2026
FY ending 31 Jan 2025	$12.6MJon Kessler$8.3MScott Cutler	$36.8M$9.3M	$5.0M	$8.2M	$132	$102	$96.7M	$471.8M	DEF 14A 13 May 2026
FY ending 31 Jan 2024	$13.4M	$22.9M	$3.9M	$2.8M	$90	$76	$55.7M	$369.2M	DEF 14A 13 May 2026
FY ending 31 Jan 2023	$13.4M	$14.4M	$5.6M	$4.0M	$73	$73	$-26.1M	$272.3M	DEF 14A 13 May 2026
FY ending 31 Jan 2022	$9.9M	$-5.5M	$2.4M	$-0.6M	$64	$93	$-44.3M	$236.0M	DEF 14A 13 May 2026
FY ending 31 Jan 2021	$9.4M	$16.5M	$2.7M	$4.6M	$126	$128	$8.8M	$240.8M	DEF 14A 13 May 2025

Each year from the newest proxy that reports it. Pay actually paid follows the SEC's definition and can be below zero when share awards fall in value. ⁿ the proxy's net income differs from the 10-K or was tagged without its scale: hover for which.

Shareholder votes

The vote count on every proposal at each meeting, from the company's 8-K.

Meeting

8-K, item 5.07, filed 26 Jun 2026

Proposal	For	Against or withheld	Abstain	Broker non-votes	For, % of for and against	Result
Proposal 1. The election of ten directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
Robert Selander	74,453,187	1,442,014	35,205	3,822,795	98.1%	–
Scott Cutler	75,542,815	353,789	33,802	3,822,795	99.5%	–
Stephen Neeleman, M.D.	75,032,571	864,875	32,960	3,822,795	98.9%	–
Adrian Dillon	74,828,471	1,066,059	35,876	3,822,795	98.6%	–
Evelyn Dilsaver	74,762,646	1,131,196	36,564	3,822,795	98.5%	–
William Gassen	75,701,238	193,566	35,602	3,822,795	99.7%	–
Debra McCowan	74,683,289	1,209,511	37,606	3,822,795	98.4%	–
Rajesh Natarajan	75,770,615	124,053	35,738	3,822,795	99.8%	–
Stuart Parker	75,662,488	231,609	36,309	3,822,795	99.7%	–
Gayle Wellborn	75,005,354	811,661	113,391	3,822,795	98.9%	–
Proposal 2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2027.
All shares voting	79,249,985	449,600	53,616	–	99.4%	–
Proposal 3. The approval, on a non-binding, advisory basis, of the fiscal 2026 compensation paid to the Company’s named executive officers.
All shares voting	74,032,348	1,852,931	45,127	3,822,795	97.6%	–
Proposal 4. The approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan.
All shares voting	75,717,841	190,964	21,601	3,822,795	99.7%	–
Proposal 5. The approval of the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan.
All shares voting	73,514,259	2,366,900	49,247	3,822,795	96.9%	–

Counts as the company reports them in its 8-K. A result shows when the filing states one. Meetings since 2023.

Dividends and buybacks

Dividend per share, the cash paid and the shares bought back, each fiscal year.

Dividend per share, each fiscal year

$0$0.5$1

'13'16'17


FY2017	–	$0	–
FY2016	–	$0	–
FY2015	–	$50.3M	–
FY2014	–	$694.0K	–
FY2013	–	$0	–

Peers

Companies in the same industry, largest first, on the same measures.

Company	Market value	Revenue, 12 months	Revenue growth	Operating margin	Net margin	ROE	P/E	EV/EBITDA
Healthequity, Inc.this company	$8.6B	$1.4B	7.3%	25.8%	17.4%	11.9%	37.5×	18.3×
Visa Inc.	$774.4B	$44.5B	14.4%	60.7%	50.8%	64.2%	34.7×	27.7×
Mastercard Inc.	$550.4B	$35.1B	16.0%	58.3%	46.3%	289.7%	34.3×	26.0×
Alibaba Group Holding Limited	$231.4B	$144.2B	2.7%	4.9%	10.1%	9.8%	15.1×	–
Accenture plc	$151.0B	$74.2B	6.5%	15.4%	11.3%	26.5%	18.4×	11.7×
Uber Technologies, Inc.	$136.0B	$55.2B	16.7%	12.1%	17.3%	35.1%	14.7×	19.3×
PDD Holdings Inc.	$112.5B	$60.1B	9.7%	21.6%	22.7%	23.7%	8.0×	–
MercadoLibre, Inc.	$91.8B	$35.2B	46.0%	8.3%	5.3%	23.8%	49.3×	25.4×
DoorDash, Inc.	$78.8B	$15.9B	33.6%	4.5%	5.3%	8.5%	93.9×	45.0×
RELX PLC	$73.7B	$12.7B	1.7%	31.6%	21.5%	87.3%	27.1×	–
Ebay Inc.	$54.0B	$12.0B	14.7%	20.5%	18.5%	47.6%	25.1×	20.3×

What the company does

HealthEquity runs tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) that employers offer, including flexible spending accounts and health reimbursement arrangements, and administers COBRA, commuter and other benefits. Around those accounts it provides payment processing, benefit information, a healthcare marketplace and investment advice. At January 31, 2026 it administered 10.6 million HSAs, with balances totaling $36.5 billion, and 7.2 million other CDBs, for 17.8 million Total Accounts in all.

Position in the market

According to the 2025 Midyear Devenir HSA Research Report, at June 2025 HealthEquity was the largest HSA provider by number of accounts and the second largest by HSA assets, with a 20% share by assets, up from 4% in December 2010. In fiscal 2025 it acquired the BenefitWallet HSA portfolio of about 616,000 HSAs plus other accounts from Conduent Business Services, LLC. It names Fidelity Investments, UnitedHealth Group's Optum and Webster Bank among its direct competitors.

From the 10-K for the year to 31 Jan 2026, filed 17 Mar 2026 · the filing ↗

Healthequity, Inc.Nasdaq · S&P MidCap 400